title: The new German allocation system for donated thoracic organs causes longer ischemia and increased costs.
abstract: OBJECTIVE
  Allocation criteria changed in 2000 as a result of Germany's new transplantation law. Before, thoracic organs were primarily allocated electively within the donor region (according to urgency and waiting time). Afterwards, all patients in Germany eligible for heart transplants were registered in a national waiting list. With the exception of high-urgency patients that are approved by an audit committee, waiting time has become the major criteria for allocation. In this study, we investigated the impact of the new allocation system on economic aspects as on clinical results.
  
  
  METHODS
  One year in the new allocation system (NA) was compared to the previous year in the old allocation system (OA) regarding explantation/transportation distance, costs, ischemia time and clinical outcome. All explantations performed by our institution within Germany were evaluated.
  
  
  RESULTS
  The number of transplantations and the spectrum was similar between the two time periods (NA vs. OA: 61 vs. 57 overall). Eighty-two percent of these explanted organs were transplanted within the donor region in the OA time period, but only 37 % in the NA period. This resulted in higher transportation distances (NA: 441 +/- 177 km vs. OA: 179 +/- 118 km), higher transportation cost (NA: EUR 4,472 +/- 2,858 per explantation vs. OA: EUR 1,858 +/- 2,293 explantation, p = 0.001), and therefore longer ischemia times in the NA period (NA: 264 +/- 56 min: OA: 208 + 61 min, p = 0.001). Perioperative results and survival after a mean clinical follow-up of 21 +/- 8 (OA) and 11 +/- 5 (NA) months were comparable (86 % vs. 87 % (p = 0.93).
  
  
  CONCLUSIONS
  Transportation distance, costs for explantation and ischemia time increased significantly with the NA period. While the clinical short-term outcome proved to be comparable, we cannot yet judge the long-term impact of the prolonged ischemia time on the development of chronic rejection.
authors.affiliation: Herzchirurgische Klinik, LMU, Klinikum Grosshadern, Munich, Germany. jan.groetzner@hch.med.uni-muenchen.de
authors.forename: J
authors.initials: J
authors.lastname: Groetzner
authors.forename: I
authors.initials: I
authors.lastname: Kaczmarek
authors.forename: B
authors.initials: B
authors.lastname: Meiser
authors.forename: M
authors.initials: M
authors.lastname: Müller
authors.forename: S
authors.initials: S
authors.lastname: Daebritz
authors.forename: P
authors.initials: P
authors.lastname: Uberfuhr
authors.forename: B
authors.initials: B
authors.lastname: Reichart
mesh_terms: D005858:Germany; D015276:Health Care Rationing / Q000191:economics*; D016027:Heart Transplantation / Q000191:economics*; D006801:Humans; D017202:Myocardial Ischemia / Q000209:etiology*; D009313:National Health Programs / Q000191:economics / Q000458:organization & administration; D012189:Retrospective Studies; D016019:Survival Analysis; D009927:Tissue and Organ Procurement / Q000191:economics / Q000458:organization & administration*; D014850:Waiting Lists